The DOI matches its Crossref record; 238 of the 238 references it cites were found in a registry or an index.
Type I interferons in infectious disease
Open accessAbstract
Type I interferons (IFNs) have diverse effects on innate and adaptive immune cells during infection with viruses, bacteria, parasites and fungi, directly and/or indirectly through the induction of other mediators. Type I IFNs are important for host defence against viruses. However, recently, they have been shown to cause immunopathology in some acute viral infections, such as influenza virus infection. Conversely, they can lead to immunosuppression during chronic viral infections, such as lymphocytic choriomeningitis virus infection. During bacterial infections, low levels of type I IFNs may be required at an early stage, to initiate cell-mediated immune responses. High concentrations of type I IFNs may block B cell responses or lead to the production of immunosuppressive molecules, and such concentrations also reduce the responsiveness of macrophages to activation by IFNγ, as has been shown for infections with Listeria monocytogenes and Mycobacterium tuberculosis. Recent studies in experimental models of tuberculosis have demonstrated that prostaglandin E2 and interleukin-1 inhibit type I IFN expression and its downstream effects, demonstrating that a cross-regulatory network of cytokines operates during infectious diseases to provide protection with minimum damage to the host.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“If type I IFNs are present early and properly localized to sites of infection, they can effectively limit viral propagation, as type I IFNs are responsible for optimal activation of macrophages, antigen presentation by DCs, and enhanced anti-viral effector T cell responses106.”
From SARS-CoV-2, COVID-19 and the aging immune system (2021) · cites this paper as [106]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,871
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Ge, D., Fellay, J., Thompson, A. J. V., Simon, J. S., Shianna, K. V., Urban, T. J., Heinzen, E. L., Qiu, P., Bertelsen, A. H., Muir, A. J., et al. (2009) · Nature · doi:10.1038/nature08309 · Cited by 3,533
Regulation of type I interferon responses
Ivashkiv, L. B., & Donlin, L. T. (2013) · Nature reviews. Immunology · doi:10.1038/nri3581 · Cited by 3,442
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
Thomas, D. L., Thio, C. L., Martin, M. P., Qi, Y., Ge, D., Ó’hUigín, C., Kidd, J. R., Kídd, K. K., Khakoo, S. I., Alexander, G., et al. (2009) · Nature · doi:10.1038/nature08463 · Cited by 2,147
Tanaka, Y., Nishida, N., Sugiyama, M., Kurosaki, M., Matsuura, K., Sakamoto, N., Nakagawa, M., Korenaga, M., Hino, K., Hige, S., et al. (2009) · Nature Genetics · doi:10.1038/ng.449 · Cited by 2,141
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., et al. (2010) · Nature · doi:10.1038/nature09247 · Cited by 1,898
Self-citationInterferons, interferon‐like cytokines, and their receptors
Pestka, S., Krause, C. D., & Walter, M. R. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00204.x · Cited by 1,845
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Study, F. T. H. C., Suppiah, V., Moldovan, M. V., Ahlenstiel, G., Berg, T., Weltman, M., Abate, M. L., Bassendine, M. F., Spengler, U., Dore, G. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.447 · Cited by 1,829
Flagged first, then by citations
Cited by
Sorted by citations
Items 801–900 of 1,004
Sun, Y., Han, X., Shang, C., Wang, Y., Xu, B., Jiang, S., Mo, Y., Wang, D., Ke, Y., & Zeng, X. (2022) · Cell Death and Disease · doi:10.1038/s41419-021-04487-w · Cited by 28
High Expression of HERV-K (HML-2) Might Stimulate Interferon in COVID-19 Patients
Guo, Y., Yang, C., Liu, Y., Li, T., Li, H., Han, J., Jia, L., Wang, X., Zhang, B., Li, J., et al. (2022) · Viruses · doi:10.3390/v14050996 · Cited by 28
Miyamoto, T., Honda, Y., Izawa, K., Kanazawa, N., Kadowaki, S., Ohnishi, H., Fujimoto, M., Kambe, N., Kase, N., Shiba, T., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.905960 · Cited by 28
Chen, Y., Bharrhan, S., Xu, J., Sharma, T., Wang, Y., Salgame, P., Zhang, J., Nargan, K., Steyn, A. J. C., Maglione, P. J., et al. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011187 · Cited by 28
Nora, R. L. D., Walburg, K. V., van Hagen, P. M., Swagemakers, S. M. A., van der Spek, P. J., Quinten, E., van Velthoven, M. E. J., Ottenhoff, T. H. M., Dik, W. A., & Haks, M. C. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-23246 · Cited by 28
Weiner, J. M., Domaszewska, T., Donkor, S. A., Kaufmann, S. H. E., Hill, P. C., & Sutherland, J. S. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz785 · Cited by 28
SHP2 deficiency promotes Staphylococcus aureus pneumonia following influenza infection
Ouyang, W., Liu, C., Pan, Y., Yu, H., Yang, L., Xia, J., & Xu, F. (2019) · Cell Proliferation · doi:10.1111/cpr.12721 · Cited by 28
The transcription factor NFAT5 limits infection-induced type I interferon responses
Encabo, H. H., Traveset, L., Argilaguet, J. M., Angulo, A., Nistal‐Villán, E., Jaiswal, R., Escalante, C. R., Gekas, C., Meyerhans, A., Aramburu, J. F., et al. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20190449 · Cited by 28
Nuclear innate sensors for nucleic acids in immunity and inflammation
Lin, H., & Cao, X. (2020) · Immunological Reviews · doi:10.1111/imr.12893 · Cited by 29
Time-Course Transcriptomic Analysis Reveals the Crucial Roles of PANoptosis in Fungal Keratitis
Xu, X., Wei, Y., Pang, J., Wei, Z., Wang, L., Chen, Q., Wang, Z., Zhang, Y., Chen, K., Peng, Y., et al. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.3.6 · Cited by 27
Zhou, Z., Zhang, M., Zhao, C., Gao, X., Zheng, W., Wu, J., Chen, C., Hu, J., Fleming, I., & Wang, D. W. (2023) · Circulation Research · doi:10.1161/circresaha.123.322619 · Cited by 27
Moon, S., Han, S., Jang, I.-H., Ryu, J., Rha, M.-S., Cho, H., Yoon, S. S., Nam, K. T., Kim, C., Park, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47963-5 · Cited by 27
Reynolds, M. B., Klein, B., McFadden, M. J., Judge, N. K., Navarrete, H. E., Michmerhuizen, B. C., Awad, D., Schultz, T. L., Harms, P. W., Zhang, L., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114607 · Cited by 27
Kim, M. S., & Kim, K. H. (2019) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2019.08.058 · Cited by 27
Arnaiz, E., Miar, A., Dias, A. G., Prasad, N., Schulze, U., Waithe, D., Nathan, J. A., Rehwinkel, J., & Harris, A. L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.779739 · Cited by 27
Pavlovic, M., Gross, C., Chili, C., Sécher, T., & Treiner, E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02097 · Cited by 27
Wang, G., Guan, J., Khan, N. U., Li, G., Shao, J., Zhou, Q., Xu, L., Huang, C., Deng, J., Zhu, H., et al. (2021) · Gut Pathogens · doi:10.1186/s13099-021-00421-9 · Cited by 27
Zebrafish MARCH8 downregulates fish IFN response by targeting MITA and TBK1 for protein degradation
Zhao, X., Dan, C., Gong, X.-Y., Li, Y., Qu, Z.-L., Sun, H.-Y., An, L., Guo, W., Gui, J., & Zhang, Y.-B. (2022) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2022.104485 · Cited by 27
Cannabidiol modulates expression of type I IFN response genes and HIV infection in macrophages
Tomer, S., Mu, W., Suryawanshi, G. W., Ng, H. L., Wang, L., Wennerberg, W., Rezek, V. K., Martin, H. A., Chen, I. S. Y., Kitchen, S. G., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.926696 · Cited by 30
Pathogenicity of Type I Interferons in Mycobacterium tuberculosis
Mundra, A., Yegiazaryan, A., Karsian, M., Alsaigh, D., Bonavida, V., Frame, M., May, N., Gargaloyan, A., Abnousian, A., & Venketaraman, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043919 · Cited by 28
An anti-cancer surveillance by the interplay between interferon-beta and retinoblastoma protein RB1
Qin, A. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1173467 · Cited by 27
Type 1 interferons: A target for immune-mediated inflammatory diseases (IMIDs)
Mathian, A., Felten, R., Alarcón-Riquelme, M. E., Psarras, A., Mertz, P., Chasset, F., Vital, E. M. J., & Arnaud, L. (2023) · Joint Bone Spine · doi:10.1016/j.jbspin.2023.105627 · Cited by 27
He, J., Liu, Z., Cao, Y., Zhang, X., Yi, C., Zhou, Y., Chen, Y., Guo, Z., Zheng, Q., & Huang, J. (2023) · Rheumatology · doi:10.1093/rheumatology/kead597 · Cited by 27
DePaula-Silva, A. B. (2024) · Viruses · doi:10.3390/v16010119 · Cited by 29
Complexities of Type I Interferon Biology: Lessons from LCMV
Suprunenko, T., & Hofer, M. J. (2019) · Viruses · doi:10.3390/v11020172 · Cited by 28
Chugh, S., Tiwari, P., Suri, C., Gupta, S. K., Singh, P., Bouzeyen, R., Kidwai, S., Srivastava, M., Rameshwaram, N. R., Kumar, Y., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2309664121 · Cited by 26
Montilla, A., Zabala, A., Calvo, I., Bosch-Juan, M., Velasco, I. T., Mata, P., Koster, M., Sierra, A., Kooistra, S. M., Soria, F. N., et al. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05648-2 · Cited by 26
Innate Antiviral Defenses Independent of Inducible IFNα/β Production
Paludan, S. R. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.06.003 · Cited by 26
Londrigan, S. L., Wakim, L. M., Smith, J. M., Haverkate, A. J., Brööks, A. G., & Reading, P. C. (2019) · Virology · doi:10.1016/j.virol.2019.11.003 · Cited by 26
Li, S., Zhu, A., Ren, K., Li, S., & Chen, L. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118064 · Cited by 26
Federspiel, J. D., Cook, K. C., Kennedy, M. A., Venkatesh, S. S., Otter, C. J., Hofstadter, W. A., Beltran, P. M. J., & Cristea, I. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107943 · Cited by 24
Biodefense Implications of New-World Hantaviruses
D’Souza, M. H., & Patel, T. R. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00925 · Cited by 26
Mechanisms of viral persistence in the brain and therapeutic approaches
Nath, A., & Johnson, T. P. (2021) · FEBS Journal · doi:10.1111/febs.15871 · Cited by 26
Peng, Y., Chen, Y., Song, M., Zhang, X., Li, P., Yu, X., Huang, Y., Zhang, N., Ji, L., Xia, L., et al. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13206 · Cited by 26
Direct type I interferon signaling in hepatocytes controls malaria
Marques-da-Silva, C., Peissig, K. B., Walker, M. P., Shiau, J. C., Bowers, C., Kyle, D. E., Vijay, R., Lindner, S. E., & Kurup, S. P. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111098 · Cited by 26
Dengue virus NS4B protein as a target for developing antivirals
Li, Q., & Kang, C. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.959727 · Cited by 27
Hwang, J., You, Y. S., Yeom, S. W., Lee, M. G., Lee, J.-H., Kim, M., & Kim, J. S. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2164215 · Cited by 29
The Antimicrobial Peptide Cathelicidin Exerts Immunomodulatory Effects via Scavenger Receptors
Amagai, R., Takahashi, T., Terui, H., Fujimura, T., Yamasaki, K., Aiba, S., & Asano, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010875 · Cited by 26
XAF1 promotes anti-RNA virus immune responses by regulating chromatin accessibility
Kuang, M., Zhao, Y., Yu, H., Li, S., Liu, T., Chen, L., Chen, J., Luo, Y., Guo, X., Wei, X., et al. (2023) · Science Advances · doi:10.1126/sciadv.adg5211 · Cited by 26
Type I Interferon Impairs Specific Antibody Responses Early during Establishment of LCMV Infection
Daugan, M., Murira, A., Mindt, B. C., Germain, A., Tarrab, E., Lapierre, P., Fritz, J. H., & Lamarre, A. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00564 · Cited by 26
Gounder, A. P., Yokoyama, C. C., Jarjour, N. N., Bricker, T. L., Edelson, B. T., & Boon, A. C. M. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007001 · Cited by 26
Nakajo–Nishimura syndrome and related proteasome-associated autoinflammatory syndromes
Ohmura, K. (2019) · Journal of Inflammation Research · doi:10.2147/jir.s194098 · Cited by 26
Kim, T. H., Kern, C., & Zhou, H. (2020) · Genes · doi:10.3390/genes11040385 · Cited by 26
Zhu, J., Deng, Y.-Q., Wang, X., Li, X.-F., Zhang, N.-N., Liu, Z.-R., Zhang, B., Qin, C.-F., & Xie, Z. (2020) · bioRxiv · doi:10.1101/2020.05.02.074021 · Cited by 29
Dynamic control of gene expression by ISGF3 and IRF1 during IFNβ and IFNγ signaling
Geetha, A. R. S. J., Fischer, K., Babadei, O., Smesnik, G., Vogt, A., Platanitis, E., Müller, M. M., Farlik, M., & Decker, T. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00092-7 · Cited by 26
Interferon-stimulated genes and their antiviral activity against SARS-CoV-2
Ortega‐Prieto, A. M., & Jiménez-Guardeño, J. M. (2024) · mBio · doi:10.1128/mbio.02100-24 · Cited by 25
Farooq, T., Hussain, M. D., Wang, Y., Kamran, A., Umar, M., Tang, Y., He, Z., & She, X. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02994-4 · Cited by 25
Antibacterial biomaterials: disruption of antibiotic tolerance for resistance prevention
Wang, M., Wang, J., Wang, F., Hu, X., He, X., James, T. D., Liu, H., & Su, J. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217368 · Cited by 26
Xi, Y., Troy, N. M., Anderson, D. R., Pena, O. M., Lynch, J. P., Phipps, S., Bosco, A., & Upham, J. W. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01351 · Cited by 25
Immunogenic Cell Death Driven by Radiation—Impact on the Tumor Microenvironment
Yamazaki, T., Vanpouille‐Box, C., Demaria, S., & Galluzzi, L. (2020) · Cancer treatment and research · doi:10.1007/978-3-030-38862-1_10 · Cited by 28
Qi, L., Wang, Y., Wang, H., & Deng, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.551413 · Cited by 25
Fraga‐Silva, T. F. D. C., Maruyama, S. R., Sorgi, C. A., Russo, E. M. D. S., Fernandes, A. P., Cardoso, C. R. D. B., Faccioli, L. H., Dias‐Baruffi, M., & Bonato, V. L. D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.599736 · Cited by 26
Candidate genes of SARS-CoV-2 gender susceptibility
Russo, C., Morello, G., Malaguarnera, R., Piro, S., Furno, D. L., & Malaguarnera, L. (2021) · Scientific Reports · doi:10.1038/s41598-021-01131-7 · Cited by 25
Pre-infection antiviral innate immunity contributes to sex differences in SARS-CoV-2 infection
Sauerwald, N., Zhang, Z., Ramos, I., Nair, V. D., Schanoski, A. S., Ge, Y., Mao, W., Alshammary, H., Gonzalez-Reiche, A. S., van de Guchte, A., et al. (2022) · Cell Systems · doi:10.1016/j.cels.2022.10.005 · Cited by 25
Rhinovirus Infection and Virus-Induced Asthma
Hayashi, Y., Sada, M., Shirai, T., Okayama, K., Kimura, R., Kondo, M., Okodo, M., Tsugawa, T., Ryo, A., & Kimura, H. (2022) · Viruses · doi:10.3390/v14122616 · Cited by 25
Makuch, E., Jasyk, I., Kula, A., Lipiński, T., & Siednienko, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314915 · Cited by 25
Pham, T. H. M., Xue, Y., Brewer, S. M., Bernstein, K. E., Quake, S. R., & Monack, D. M. (2023) · Science Advances · doi:10.1126/sciadv.add4333 · Cited by 25
Protective versus Pathogenic Type I Interferon Responses during Virus Infections
Jung, K. I., McKenna, S., Vijayamahantesh, V., He, Y., & Hahm, B. (2023) · Viruses · doi:10.3390/v15091916 · Cited by 25
Nucleotide modifications enable rational design of TLR7-selective ligands by blocking RNase cleavage
Tong, A.-J., Leylek, R. A., Herzner, A., Rigas, D., Wichner, S. M., Blanchette, C., Tähtinen, S., Kemball, C. C., Mellman, I., Haley, B., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20230341 · Cited by 27
Dodantenna, N., Cha, J.-W., Chathuranga, K., Chathuranga, W. A. G., Weerawardhana, A., Ranathunga, L., Kim, Y., Jheong, W., & Lee, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042099 · Cited by 25
Type I Interferon in Malaria: A Balancing Act
Mooney, J. P., Wassmer, S. C., & Hafalla, J. C. R. (2017) · Trends in Parasitology · doi:10.1016/j.pt.2016.12.010 · Cited by 25
Zika virus infection confers protection against West Nile virus challenge in mice
Vázquez-Calvo, Á., Blázquez, A.-B., Escribano-Romero, E., Merino-Ramos, T., Sáiz, J., Martín-Acebes, M. A., & de Oya, N. J. (2017) · Emerging Microbes & Infections · doi:10.1038/emi.2017.68 · Cited by 25
Rivas-Santiago, C., & Guerrero, G. G. (2017) · BioMed Research International · doi:10.1155/2017/8796760 · Cited by 25
The interferon stimulated gene viperin, restricts Shigella. flexneri in vitro
Helbig, K. J., Teh, M. Y., Crosse, K. M., Monson, E. A., Smith, M., Tran, E. N. H., Standish, A. J., Morona, R., & Beard, M. R. (2019) · Scientific Reports · doi:10.1038/s41598-019-52130-8 · Cited by 25
Clarke, E. C., & Bradfute, S. B. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2019.104703 · Cited by 25
Gobillot, T. A., Humes, D. G., Sharma, A., Kikawa, C., & Overbaugh, J. M. (2020) · Viruses · doi:10.3390/v12050503 · Cited by 25
Cytomegaloviruses and Macrophages—Friends and Foes From Early on?
Baasch, S., Ruzsics, Z., & Henneke, P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00793 · Cited by 27
Vig, S., Lambooij, J. M., Dekkers, M. C., Otto, F., Carlotti, F., Guigas, B., & Zaldumbide, A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.991632 · Cited by 24
The Complexity of Interferon Signaling in Host Defense against Protozoan Parasite Infection
Deng, S., Graham, M. L., & Chen, X. (2023) · Pathogens · doi:10.3390/pathogens12020319 · Cited by 24
Conserved and divergent arms of the antiviral response in the duplicated genomes of salmonid fishes
Clark, T. C., Naseer, S., Gundappa, M. K., Laurent, A., Perquis, A., Collet, B., Macqueen, D. J., Martín, S., & Boudinot, P. (2023) · Genomics · doi:10.1016/j.ygeno.2023.110663 · Cited by 26
Boosting the human antiviral response in conjunction with natural plant products
Srivastava, R., Dubey, N. K., Sharma, M., Kharkwal, H., Bajpai, R., & Srivastava, R. (2025) · Frontiers in Natural Products · doi:10.3389/fntpr.2024.1470639 · Cited by 24
Seeking innovative concepts in development of antiviral drug combinations
Kainov, D. E., Ravlo, E., & Ianevski, A. (2025) · Antiviral Research · doi:10.1016/j.antiviral.2025.106079 · Cited by 24
Tscherne, A., Guardado‐Calvo, P., Clark, J. J., Krause, R., & Krammer, F. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1575112 · Cited by 24
Oropouche virus infects human trophoblasts and placenta explants
Megli, C., Zack, R., McGaughey, J. J., Hoehl, R. M., Snisky, T., Hartman, A. L., & McMillen, C. M. (2025) · Nature Communications · doi:10.1038/s41467-025-61138-w · Cited by 24
Molecular Mechanisms of Sepsis-Associated Acute Kidney Injury
Hato, T., & Dagher, P. C. (2025) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000809 · Cited by 24
Rieder, M., Wirth, L., Pollmeier, L., Jeserich, M., Goller, I., Baldus, N., Schmid, B., Busch, H.-J., Hofmann, M., Thimme, R., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa741 · Cited by 25
Rodrigues, P. R. S., Alrubayyi, A., Pring, E., Bart, V. M. T., Jones, R. E., Coveney, C. R., Lu, F., Tellier, M., Maleki-Toyserkani, S., Richter, F. C., et al. (2020) · Oxford Open Immunology · doi:10.1093/oxfimm/iqaa005 · Cited by 26
Zhang, N., Shi, H., Yan, M., & Liu, G. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001033 · Cited by 24
Ahn, J., Park, J., Kim, D., Lee, T., Jung, D., Kim, Y.-J., Lee, Y., Lee, Y., Seo, I.-S., Song, E., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.738070 · Cited by 24
Swainson, L. A., Sharma, A., Ghneim, K., Ribeiro, S. P., Wilkinson, P. A., Dunham, R. M., Albright, R. G., Wong, S., Estes, J. D., Piatak, M., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.153046 · Cited by 24
RIG-I–like Receptor Regulation of Immune Cell Function and Therapeutic Implications
Solstad, A., Hogaboam, O., Forero, A., & Hemann, E. A. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2200395 · Cited by 25
Interferon Signaling in the Endometrium and in Endometriosis
Park, Y., & Han, S. J. (2022) · Biomolecules · doi:10.3390/biom12111554 · Cited by 25
The immune response to lumpy skin disease virus in cattle is influenced by inoculation route
Fay, P. C., Wijesiriwardana, N., Munyanduki, H. M., Sanz‐Bernardo, B., Lewis, I., Haga, I. R., Moffat, K., van Vliet, A. H. M., Hope, J. C., Graham, S. P., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1051008 · Cited by 24
RetractedColdbeck-Shackley, R. C., Romeo, O., Rosli, S., Gearing, L. J., Gould, J. A., Lim, S. S., der Hoek, K. H. V., Eyre, N. S., Shue, B., Robertson, S. A., et al. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1010843 · Cited by 24
Ren, J., Antony, F., Rouse, B. T., & Suryawanshi, A. S. (2023) · Pathogens · doi:10.3390/pathogens12030437 · Cited by 25
Roles of inflammasomes in viral myocarditis
Xu, J., Zhou, Z., Zheng, Y., Yang, S., Huang, K., & Li, H. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1149911 · Cited by 25
Histone deacetylase 6’s function in viral infection, innate immunity, and disease: latest advances
Qu, M., Zhang, H., Cheng, P., Wubshet, A. K., Yin, X., Wang, X., & Sun, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1216548 · Cited by 24
Myeloid‐derived suppressor cells in the therapy of autoimmune diseases
Bekić, M., & Tomić, S. (2023) · European Journal of Immunology · doi:10.1002/eji.202250345 · Cited by 24
Al-Adwi, Y., Atzeni, I. M., der Meer, B. D., van der Leij, M. J., Varkevisser, R. D. M., Kroesen, B., Stel, A. J., Timens, W., Gan, C. T., van Goor, H., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104883 · Cited by 24
Ivanova, E. N., Shwetar, J., Devlin, J. C., Buus, T. B., Gray-Gaillard, S. L., Koide, A., Cornelius, A. R., Samanovic, M. I., Herrera, A. M., Mimitou, E. P., et al. (2023) · iScience · doi:10.1016/j.isci.2023.108572 · Cited by 28
Soliman, M., Srikrishna, G., & Balagopal, A. (2017) · Current HIV/AIDS Reports · doi:10.1007/s11904-017-0357-9 · Cited by 28
Woodby, B. L., Songock, W. K., Scott, M. L., Raikhy, G., & Bodily, J. M. (2018) · Journal of Virology · doi:10.1128/jvi.01714-17 · Cited by 24
NLRP2 negatively regulates antiviral immunity by interacting with TBK1
Yang, Y., Lang, X., Sun, S., Gao, C., Hu, J., Ding, S., Li, J., Li, Y., Wang, F., & Gong, T. (2018) · European Journal of Immunology · doi:10.1002/eji.201847589 · Cited by 24
Platelets and IgE: Shaping the Innate Immune Response in Systemic Lupus Erythematosus
Brilland, B., Scherlinger, M., Khoryati, L., Goret, J., Duffau, P., Lazaro, E., Charrier, M., Guillotin, V., Richez, C., & Blanco, P. (2019) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-019-08744-x · Cited by 26
Mariani, M. K., Dasmeh, P., Fortin, A., Caron, E., Kalamujic, M., Harrison, A. N., Hotea, D. I., Kasumba, D. M., Cervantes-Ortiz, S., Mukawera, E., et al. (2019) · Cells · doi:10.3390/cells8080919 · Cited by 24
The alternative cap-binding complex is required for antiviral defense in vivo
Gebhardt, A., Bergant, V., Schnepf, D., Moser, M., Meiler, A., Togbe, D., Mackowiak, C., Reinert, L. S., Paludan, S. R., Ryffel, B., et al. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1008155 · Cited by 26
Ambrose, R. L., Brice, A. M., Caputo, A. T., Alexander, M. R., Tribolet, L., Liu, Y. C., Adams, T. E., Bean, A. G. D., & Stewart, C. R. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e04115 · Cited by 24
Liang, S., Xie, M., Tang, J., Wang, M., Zhang, D., & Hou, S. (2020) · Veterinary Microbiology · doi:10.1016/j.vetmic.2020.108813 · Cited by 24
Riedelberger, M., Penninger, P., Tscherner, M., Hadriga, B., Brunnhofer, C., Jenull, S., Stoiber, A., Bourgeois, C., Petryshyn, A., Glaser, W., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101121 · Cited by 23
Non-transcriptional IRF7 interacts with NF-κB to inhibit viral inflammation
Fan, S., Popli, S., Chakravarty, S., Chakravarti, R., & Chattopadhyay, S. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107200 · Cited by 25
Metadata
- Authors
- McNab, F., Mayer-Barber, K., Sher, A., Wack, A., & O'Garra, A.
- Affiliations
- GlaxoSmithKline (United Kingdom) (GB)
- National Institutes of Health (US)
- National Institute for Medical Research (GB)
- Venue
- Nature Reviews Immunology
- Published
- 2015-01-23
- Volume
- 15
- Issue
- 2
- Pages
- 87-103
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC7162685
- OpenAlex
- W2091129202
- Cited by
- 2,780
- References
- 238
- Citations by year
- 2026: 263 · 2025: 333 · 2024: 364 · 2023: 330 · 2022: 330 · 2021: 307 · 2020: 194 · 2019: 160 · 2018: 166 · 2017: 169 · 2016: 119 · 2015: 44
- FWCI
- 15.67
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Wellcome Trust (FC001126)
- Francis Crick Institute (10206, 10126)
- Cancer Research UK (FC001126)
- National Institutes of Health
- Medical Research Council (U117597139, U117565642)
- National Institute of Allergy and Infectious Diseases
- FP7 Ideas: European Research Council (294682)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Keywords
- type I interferon, innate immunity, viral infection, bacterial infection, parasitic infection, fungal infection, immunopathology, influenza virus, lymphocytic choriomeningitis virus, chronic viral infection, immunosuppression, B cell response, macrophage activation, Listeria monocytogenes, Mycobacterium tuberculosis, prostaglandin E2, interleukin-1, host defense
- MeSH terms
- Animals, Bacterial Infections, Communicable Diseases, Humans, Interferon Type I, Mycoses, Parasitic Diseases, Virus Diseases, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
